This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2. SC O'Neill , E Kaufman , T DeMarco (2008) Changes in diet and physical activity following brca1/2 testing. J Psychosoc Oncol 26, 63–80.
3. J Quach , K Porter , H Leventhal (2009) Health behaviors among Ashkenazi Jewish individuals receiving counseling for brca1 and brca2 mutations. Fam Cancer 8, 241–250.
5. S Chao , JS Roberts , TM Marteau (2008) Health behavior changes after genetic risk assessment for Alzheimer disease: the reveal study. Alzheimer Dis Assoc Disord 22, 94–97.
6. JA Vernarelli , JS Roberts , S Hiraki (2010) Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr 91, 1402–1407.
7. CS Hendershot , JM Otto , SE Collins (2010) Evaluation of a brief web-based genetic feedback intervention for reducing alcohol-related health risks associated with aldh2. Ann Behav Med 40, 77–88.
10. JP Terdiman , PG Conrad & MH Sleisenger (1999) Genetic testing in hereditary colorectal cancer: indications and procedures. Am J Gastroenterol 94, 2344–2356.
12. YJ Chen , C Chen , DC Wu (2006) Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks. Int J Cancer 119, 2827–2831.
13. A Yokoyama & T Omori (2003) Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol 33, 111–121.
14. LA Farrer , LA Cupples , CM van Duijn (1995) Apolipoprotein e genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 38, 797–808.
15. LA Cupples , LA Farrer , AD Sadovnick (2004) Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the reveal study. Genet Med 6, 192–196.
16. A Scuteri , S Sanna , WM Chen . (2007) Genome-wide association scan shows genetic variants in the fto gene are associated with obesity-related traits. PLoS Genet 3, e115.
17. RJ Loos & C Bouchard (2008) Fto: the first gene contributing to common forms of human obesity. Obes Rev 9, 246–250.
18. S Peng , Y Zhu , F Xu . (2011) Fto gene polymorphisms and obesity risk: a meta-analysis. BMC Med 9, 71.
19. C Shaw , K Abrams & TM Marteau (1999) Psychological impact of predicting individuals’ risks of illness: a systematic review. Soc Sci Med 49, 1571–1598.
21. SC O'Neill , HB Valdimarsdottir , TA Demarco (2010) Brca1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Res Treat 124, 755–764.
22. MD Schwartz , C Isaacs , KD Graves (2011) Long-term outcomes of brca1/brca2 testing: risk reduction and surveillance. Cancer 118, 510–517.
23. R Calderon-Margalit & O Paltiel (2004) Prevention of breast cancer in women who carry brca1 or brca2 mutations: a critical review of the literature. Int J Cancer 112, 357–364.
24. KA Metcalfe , D Birenbaum-Carmeli , J Lubinski (2008) International variation in rates of uptake of preventive options in brca1 and brca2 mutation carriers. Int J Cancer 122, 2017–2022.
25. H Meijers-Heijboer , CT Brekelmans , M Menke-Pluymers (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a brca1 or brca2 mutation. J Clin Oncol 21, 1675–1681.
26. KA Metcalfe , J Lubinski , P Ghadirian (2008) Predictors of contralateral prophylactic mastectomy in women with a brca1 or brca2 mutation: the hereditary breast cancer clinical study group. J Clin Oncol 26, 1093–1097.
27. KA Metcalfe , WD Foulkes , C Kim-Sing (2008) Family history as a predictor of uptake of cancer preventive procedures by women with a brca1 or brca2 mutation. Clin Genet 73, 474–479.
28. KA Phillips , MA Jenkins , GJ Lindeman (2006) Risk-reducing surgery, screening and chemoprevention practices of brca1 and brca2 mutation carriers: a prospective cohort study. Clin Genet 70, 198–206.
29. RM Ceballos , PA Newcomb , JM Beasley (2008) Colorectal cancer cases and relatives of cases indicate similar willingness to receive and disclose genetic information. Genet Test 12, 415–420.
31. MJ Carpenter , C Strange , Y Jones (2007) Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med 33, 22–28.
32. C Strange , R Dickson , C Carter (2004) Genetic testing for alpha1-antitrypsin deficiency. Genet Med 6, 204–210.
33. MJ Carpenter , AJ Alberg , KM Gray (2010) Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers. Clin Trials 7, 157–166.
34. SM Markowitz , ER Park , LM Delahanty (2011) Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care 34, 568–573.
35. JS Roberts & SM Tersegno (2010) Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions. Future Neurol 5, 501–517.
36. RC Green , JS Roberts , LA Cupples (2009) Disclosure of apoE genotype for risk of Alzheimer's disease. N Engl J Med 361, 245–254.
37. JS Roberts , LA Cupples , N Relkin (2005) Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatr Neurol 18, 250–255.
38. CS Bloss , NJ Schork & EJ Topol (2011) Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 364, 524–534.
39. IM Rosenstock (1966) Why people use health services. Milbank Mem Fund Q 44, Suppl., 94–127.
41. A Alamian , I Rouleau , J Simard (2006) Use of dietary supplements among women at high risk of hereditary breast and ovarian cancer (HBOC) tested for cancer susceptibility. Nutr Cancer 54, 157–165.
42. M Nichter & JJ Thompson (2006) For my wellness, not just my illness: North Americans’ use of dietary supplements. Cult Med Psychiatry 30, 175–222.
43. S Reichenbach & P Juni (2012) Medical food and food supplements: not always as safe as generally assumed. Ann Intern Med 156, 894–895.